1. Home
  2. OLMA vs KIND Comparison

OLMA vs KIND Comparison

Compare OLMA & KIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • KIND
  • Stock Information
  • Founded
  • OLMA 2006
  • KIND 2011
  • Country
  • OLMA United States
  • KIND United States
  • Employees
  • OLMA N/A
  • KIND N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • KIND Computer Software: Programming Data Processing
  • Sector
  • OLMA Health Care
  • KIND Technology
  • Exchange
  • OLMA Nasdaq
  • KIND Nasdaq
  • Market Cap
  • OLMA 465.4M
  • KIND 974.5M
  • IPO Year
  • OLMA 2020
  • KIND N/A
  • Fundamental
  • Price
  • OLMA $6.10
  • KIND $2.42
  • Analyst Decision
  • OLMA Strong Buy
  • KIND Hold
  • Analyst Count
  • OLMA 5
  • KIND 2
  • Target Price
  • OLMA $26.25
  • KIND $2.75
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • KIND 2.3M
  • Earning Date
  • OLMA 11-12-2024
  • KIND 11-06-2024
  • Dividend Yield
  • OLMA N/A
  • KIND N/A
  • EPS Growth
  • OLMA N/A
  • KIND N/A
  • EPS
  • OLMA N/A
  • KIND N/A
  • Revenue
  • OLMA N/A
  • KIND $237,605,000.00
  • Revenue This Year
  • OLMA N/A
  • KIND $14.90
  • Revenue Next Year
  • OLMA N/A
  • KIND $14.61
  • P/E Ratio
  • OLMA N/A
  • KIND N/A
  • Revenue Growth
  • OLMA N/A
  • KIND 9.99
  • 52 Week Low
  • OLMA $5.56
  • KIND $1.32
  • 52 Week High
  • OLMA $16.78
  • KIND $3.00
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • KIND 41.53
  • Support Level
  • OLMA $5.56
  • KIND $2.26
  • Resistance Level
  • OLMA $6.87
  • KIND $2.68
  • Average True Range (ATR)
  • OLMA 0.81
  • KIND 0.13
  • MACD
  • OLMA -0.28
  • KIND -0.03
  • Stochastic Oscillator
  • OLMA 10.12
  • KIND 16.04

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About KIND Nextdoor Holdings Inc.

Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services.

Share on Social Networks: